Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06889090Not yet recruiting
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain (2 arms), sponsored by Cairo University. Primary endpoint: Quality of Recovery-15 at 24 hours. Planned start Apr 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06889090.